Pebble Square
Venture Round in 2025
Pebble Square is a technology company specializing in the development of Processing-In-Memory (PIM) architecture, a cutting-edge solution designed to enhance the performance and power efficiency of artificial intelligence systems. Their innovative technology enables real-time data processing and the creation of application-specific products, such as neuromorphic systems and edge AI chip designs, with a focus on benefiting socially underprivileged and vulnerable groups.
Washswat Inc. is a South Korean company established in 2015 that specializes in on-demand mobile laundry services. Based in Seoul, it operates through a network of specialized facilities and personnel that handle washing and drying. Initially launched in the Gangnam area, known for its concentration of high-end cleaners, Washswat has strategically expanded its services to various regions, including Seongnam, Hanam, Goyang, Gwangmyeong, Yongin, Suwon, Anyang, and Gwacheon, becoming a leader in mobile laundry services in Korea. The company utilizes IT technology to enhance its offerings, providing customers with a mobile application that allows them to track their laundry process and schedule pickups and deliveries from their doorstep. Washswat's meticulous approach ensures that every item is carefully recorded to prevent loss, thereby delivering a reliable service tailored to meet customer needs.
Solmedix
Venture Round in 2024
Solmedix is a company focused on the development and commercialization of innovative medical devices aimed at enhancing advanced treatments and diagnoses. Utilizing its MOSAIC Platform, Solmedix provides a comprehensive range of services that include the diagnosis of medical device concepts, prototype production, patent assistance, and support for national projects. The company also engages in empirical and preclinical research, prototype development, technology transfer, and product launch. By offering these services, Solmedix facilitates the smooth commercialization of startups and innovators with promising medical device ideas, helping to bring new solutions to the healthcare market.
Lucas develops a system to detect, measure, categorize and track nodules in the screening CT images.
Allround Doctors
Series A in 2024
Allround Doctors is a digital healthcare startup that develops digital medical devices for cancer patients.
Bold9 is a logistics services provider that specializes in supporting online sellers by optimizing their delivery requirements and facilitating efficient product sourcing. The company aims to create a comprehensive platform that enhances the logistics process for e-commerce businesses, allowing them to fulfill their orders promptly and effectively. Through its focus on logistics, Bold9 helps sellers streamline operations and improve overall customer satisfaction.
Nventric is a medical device company focused on developing innovative solutions for neurovascular, coronary heart, and peripheral vascular applications. The company specializes in creating devices aimed at addressing critical medical conditions, particularly those related to ischemic stroke. One of its key products is a stent retriever designed to be inserted into the artery in the leg, facilitating the removal of blood clots that lead to arterial occlusion. This technology enhances the ability of healthcare professionals to effectively treat ischemic stroke, ultimately improving patient outcomes. Nventric's commitment to advancing medical devices underscores its role in the healthcare sector, addressing significant challenges in vascular health.
GEXVal Inc. is a drug discovery company based in Fujisawa, Japan, founded in 2018. The company focuses on the research and development of innovative treatments for rare and incurable diseases, particularly in the fields of psychiatry, neurology, and pulmonary arterial hypertension. GEXVal is dedicated to addressing the needs of patients and families affected by these conditions by providing cost-effective treatment options that aim to enhance health and improve quality of life. Through its specialized research efforts, GEXVal seeks to develop compounds that target intractable diseases, enabling physicians to offer better therapeutic solutions to their patients.
Edgecare is a manufacturing company that specializes in developing medical devices. These include precision and optical devices designed to enhance healthcare quality and affordability. The company's portfolio includes bladder image scanners for urinary diagnosis, enabling early disease detection and treatment.
Novorex is a biotechnology company focused on the development of small-molecule drugs aimed at treating oncology and neurological diseases. The company employs advanced technologies, including artificial intelligence, to enhance the efficiency of drug development. By integrating biophysical analysis with in vitro and in vivo assays, Novorex aims to create innovative therapeutic solutions for patients with cancer and central nervous system disorders. Through its research and development efforts, Novorex seeks to provide advanced treatment options that meet the needs of patients facing serious health challenges.
Brexogen is a biotechnology company focused on the research and development of cell therapies aimed at addressing incurable diseases through the use of stem cell exosomes. The company specializes in optimizing parental cells for enhanced exosome production, which offers superior proliferation and secretion capabilities compared to traditional stem cells. This innovative approach not only facilitates mass production of exosomes but also serves as a critical step toward the commercialization of these therapies, ultimately providing physicians with effective treatment options for challenging medical conditions.
Right Route
Seed Round in 2023
Right Route is an e-commerce company for clothes.
Exorenal
Seed Round in 2023
Exorenal is a medical device company based in the United States that focuses on developing innovative technologies for artificial kidneys and kidney dialysis devices. The company specializes in creating a novel hemodialysis unit that features a fully disposable dialysate compartment, catering to the growing demand for home hemodialysis solutions. By emphasizing simplification and lightweight design, Exorenal aims to enhance convenience for patients, allowing them to manage their hemodialysis treatments in the comfort of their own homes. This approach addresses critical needs in the home care market, improving the overall experience and accessibility of hemodialysis therapy.
Brexogen
Venture Round in 2023
Brexogen is a biotechnology company focused on the research and development of cell therapies aimed at addressing incurable diseases through the use of stem cell exosomes. The company specializes in optimizing parental cells for enhanced exosome production, which offers superior proliferation and secretion capabilities compared to traditional stem cells. This innovative approach not only facilitates mass production of exosomes but also serves as a critical step toward the commercialization of these therapies, ultimately providing physicians with effective treatment options for challenging medical conditions.
iChems
Venture Round in 2023
iChems is a manufacturer focused on the research and development of precursor materials specifically designed for semiconductor wafers. The company produces substances utilized in atomic layer deposition and organic metallurgical compounds, catering to the needs of various general semiconductor companies and precursor manufacturing affiliates. With a proven history of supplying major semiconductor firms in Korea, iChems has established itself as a reliable provider of innovative precursor solutions, supporting the advancement of semiconductor technology.
FatiAbGen
Seed Round in 2023
FatiAbGen is a prominent biotechnology company focused on developing monoclonal antibody-based therapies for the treatment of various cancers, immunological disorders, and infectious diseases. The company boasts a broad pre-clinical pipeline, utilizing its innovative therapeutic antibodies to address oncology and allergy-related conditions. FatiAbGen specializes in enhancing linker technology to diversify payloads applied to solid tumors, effectively lowering the risks of antibody-drug conjugate-related adverse events and toxicity. By regulating stem cell fate, the company aims to provide significant relief to patients suffering from these challenging health issues.
Nuvilab is a company that focuses on transforming the food industry through innovative technology aimed at enhancing environmental sustainability and personal well-being. Its core product, the Nuvilab AI Food Scanner, employs advanced instant food recognition technology to accurately identify food types and volumes. By leveraging big data, Nuvilab integrates various food-related information, including details about leftovers, user preferences, and optimized menu recommendations. This comprehensive approach allows the company to provide users with personalized nutritional reports and guidelines, promoting healthier dietary habits. Through its solutions, Nuvilab aims to facilitate a more informed and sustainable approach to food consumption.
Avelos Therapeutics
Series A in 2022
Avelos Therapeutics is a clinical-stage precision medicine company specializing in the development of targeted therapeutics for cancer treatment. They focus on creating biomarker-driven therapies centered around cell cycle regulation, DNA damage response, and historically 'undruggable' cancer targets. The company aims to enable more effective cancer treatments by identifying and targeting specific biomarkers.
MDSquare
Seed Round in 2022
MDSquare is a mobile telemedicine consultation service company.
GSIL Co., Ltd. specializes in safety management technology tailored for the construction industry. The company offers a comprehensive safety solution known as Saint, which utilizes real-time IoT technology to monitor the location and status of workers, as well as to manage equipment through NFC tags. This platform enables safety managers to precheck hazardous factors, analyze the likelihood of accidents, and respond effectively to crises based on accurate data. By addressing the specific needs of field workers, GSIL aims to enhance safety measures, reduce overtime, and ultimately promote a culture of safety in the workplace. Their mission, encapsulated in the phrase "Good Safety in Life," reflects their commitment to providing effective safety solutions that improve the overall well-being of workers in hazardous environments.
Rznomics is a biotechnology company founded by Professor Lee Sung-wook's lab, specializing in the development of ribonucleic acid-based gene therapies. The company focuses on creating innovative biopharmaceuticals aimed at addressing significant medical challenges, particularly in the treatment of liver cancer, various cancers, degenerative neurological diseases, and hereditary disorders. Rznomics has been recognized for its technological advancements and was selected by the TIPS program, highlighting its commitment to addressing medical needs that remain unmet in current healthcare. Through its research and development efforts, Rznomics aims to enable medical practitioners to effectively treat complex conditions such as cancer and Alzheimer's disease.
Armored Fresh
Series A in 2022
Armored Fresh is a food company specializing in the production of plant-based cheese made from almond milk. Committed to promoting sustainability, the company aims to create cheese alternatives that are not only better for people's health but also for animals and the environment. Armored Fresh focuses on developing a product that mimics the taste and texture of traditional dairy cheese. Its offerings include vegan cube cheese, which features a soft texture and savory flavors, designed to enhance nutritional content and protein levels comparable to those of cow cheese. Through its innovative technology, Armored Fresh strives to deliver a satisfying and nutritious alternative for consumers seeking plant-based options.
Vendit specializes in providing automation solutions for the hospitality industry, focusing on hotels. The company manufactures self-operating kiosks and cloud management systems designed to streamline online reservations and check-in processes. By employing advanced technologies such as AI for adult authentication and automatic key management, Vendit's products facilitate seamless integration with online travel agencies. Additionally, the company offers automatic dashboards that enable hotels to efficiently manage operations, thereby reducing labor costs and maximizing sales opportunities. Through its innovative solutions, Vendit aims to enhance operational efficiency and improve the overall guest experience in the hotel sector.
Precious Writing
Seed Round in 2022
Precious Writing is an e-learning platform that offers language education solutions using big data and artificial intelligence.
Selecxine
Series B in 2022
Selecxine is a biopharmaceutical development company focused on creating innovative immunotherapeutics for cancer treatment. The company specializes in the development of anti-cancer drugs that enhance the body's immune response through a unique antibody development process. By utilizing a cutting-edge platform for functional antibody screening, Selecxine aims to regulate the activity of cytokines, which are crucial for activating immune cells. This approach is designed to provide safer and more effective therapeutic options for cancer patients, ultimately improving their survival rates and quality of life.
Autotelic Bio
Series B in 2022
Autotelic Bio is a biotechnology company specializing in the research and development of innovative anti-cancer drugs. The company aims to enhance the efficacy and reduce the side effects of existing oncology treatments through the precise targeting and optimization of therapies. In addition to its focus on oncology, Autotelic Bio is also involved in developing immuno-oncology drugs that address conditions such as diabetes, hypertension, and diseases affecting the central nervous system. By pursuing advanced therapeutic solutions, Autotelic Bio seeks to improve patient outcomes and contribute to the evolving field of cancer treatment.
We Hudling
Series A in 2022
Wehuddling provides corporate and individual breakfast and lunch subscriptions. The company offers secure and free meal shipping services.
BnH Research
Series B in 2022
BnH Research is a drug development and research firm focused on creating therapeutics for patients with chronic conditions. The company specializes in verifying the efficacy of new and existing drug candidates, providing essential contract-based research services to pharmaceutical companies. BnH Research aims to address unmet medical needs by developing drug candidates that particularly enhance cortical plasticity, which is crucial for treating central nervous system conditions such as Alzheimer's Disease, PTSD, addiction, amblyopia, and stroke. Through its innovative approaches, the firm seeks to improve patient outcomes and advance the field of drug development.
Coactus
Seed Round in 2022
Coactus is a social venture that creates an innovative business to make a better world. They do deaf taxi driver's taxi service, 'Goyohan Taxi'. In order to help communicate with passengers, they developed a communication tool 'Goyohan', which operates in two tablet PC's inside the taxi. Goyohan Taxi has 26 deaf taxi drivers in 5 areas, with 10 taxi companies. Within 2020, they aim to create 100 deaf taxi drivers.
Bastera is a biotech company with the primary goal of developing groundbreaking treatments for cardiovascular and cancer diseases. Their approach involves targeting new redox signaling pathways, aiming to pioneer "first-in-class" therapies in these fields. Vastera was established in 2018 when SangWon Kang, a professor at Ewha Womans University, transferred a patent based on research results on redox signaling in blood vessels and cancer.
Wefun
Venture Round in 2022
Wefun is a company focused on managing office snacks, offering a diverse selection to meet the tastes of employees. They employ a dedicated snack curator who conducts personalized consultations to understand client preferences and recommend new products. This tailored approach allows businesses to order weekly snacks that align with the specific tastes of their workforce, enhancing the overall workplace experience.
Pinpoint
Venture Round in 2022
Pinpoint is a proptech company focused on developing small and medium-sized office spaces. It aims to innovate within this market by integrating digital technologies with physical space to improve user experiences. The company offers a space-based service platform that enhances communication and management for building owners, operators, lessees, and users. Through this innovative approach, Pinpoint provides various digital functions and spatial content, addressing the need for a modernized office environment that aligns with contemporary digital demands.
TMD Lab
Venture Round in 2022
TMD Lab is a company focused on the research and development of innovative medical devices and advanced biomedicine, utilizing shape memory polymer and nanovesicle-based technologies. Their proprietary shape memory polymer technology allows for the creation of customized products that adapt to the unique shapes of individual bodies or objects. This capability enables various industries, including healthcare, printing, textiles, and materials, to develop products that enhance health outcomes and promote innovation. By leveraging these advanced materials, TMD Lab aims to contribute significantly to the evolution of medical and industrial applications.
CT Cells
Venture Round in 2022
CT Cells is a total solution provider from precise diagnostics to personalized therapeutics.
Lucas develops a system to detect, measure, categorize and track nodules in the screening CT images.
Creatz is a sports consulting platform that leverages artificially generated data to enhance athletic performance, particularly in golf. The company specializes in the manufacturing of advanced golf simulators designed for practice purposes. These simulators utilize high-speed cameras and radar technology to measure and analyze critical aspects of a golfer's performance, including club and ball dynamics, as well as swing mechanics. By visually presenting the data, Creatz enables golf instructors to provide targeted feedback and guidance, helping golfers improve their skills and overall game.
PDC*line Pharma
Series B in 2021
PDC*line Pharma is a clinical-stage biotech company based in France and Belgium, specializing in the development of innovative active immunotherapies for cancer. The company utilizes a proprietary allogeneic cell line of Plasmacytoid Dendritic Cells (PDC*line) that are loaded with cancer antigens to enhance the immune response against tumors. Founded in April 2014 in Grenoble by Laurent Levy and Joel Plumas, PDC*line Pharma evolved from a research program at the French Blood Bank that developed the PDC line from a patient with PDC leukemia. The company aims to provide more effective cancer treatments by leveraging these potent and scalable dendritic cell lines to boost antitumor responses, including those targeting neoantigens, and to stimulate specific cytotoxic T-cell activity beyond what conventional vaccines can achieve. Eric Halioua joined the company in 2016 and has since served as President and CEO, guiding its progression into clinical development.
TFJ Global is a chemical manufacturing company specializing in eco-friendly water-repellent technology for textiles. It produces a non-fluorine nanotechnology product that forms a protective layer on fabrics, resisting stains and maintaining high antibacterial properties even after multiple washes. This enhances the functionality, durability, and longevity of clothing and other textile products.
Beyond Honeycomb
Series A in 2021
Beyond Honeycomb is a food-tech company focused on creating advanced kitchen robotics powered by artificial intelligence. Its primary offering, the AI Chef, is designed to replicate gourmet dishes crafted by world-class chefs, achieving precise texture and taste at a molecular level. Utilizing cutting-edge molecular sensor technology, Beyond Honeycomb's robots analyze the cooking process, monitoring various heat sources and temperature control mechanisms to ensure fidelity to the chef's recipes. This innovative approach enables customers to enjoy high-quality culinary experiences at more accessible price points, making gourmet cooking feasible for a broader audience.
Ticaros is a biotechnology company focused on the development of immune anti-cancer drugs, specifically utilizing CAR-T cell therapy. The company's innovative technology aims to treat patients with relapsed and refractory cancers by enhancing the effectiveness of T cells. This is achieved through the selective inhibition of CTLA4 function in cancer-specific T cells, which increases their capacity to eliminate tumors. Ticaros modifies the CAR construct to enhance the binding affinity of CAR-T cells to tumor cells, providing patients with access to novel cancer treatments that aim to improve therapeutic outcomes.
Space F is an application industry platform business company that researches and develops cell farming technology.
SOL Bio is a biotechnology company focused on the research and development of exosome-based in vitro diagnostic products. The company utilizes advanced exosome isolation technology to create innovative diagnostic tools aimed at the early detection of various cancers and chronic diseases. By employing an on-site biosensor, SOL Bio enables researchers and healthcare professionals to access novel drugs and address areas with significant unmet medical needs. Through its platform, SOL Bio is positioned to contribute to advancements in cancer diagnostics and improve patient outcomes.
Solmedix is a company focused on the development and commercialization of innovative medical devices aimed at enhancing advanced treatments and diagnoses. Utilizing its MOSAIC Platform, Solmedix provides a comprehensive range of services that include the diagnosis of medical device concepts, prototype production, patent assistance, and support for national projects. The company also engages in empirical and preclinical research, prototype development, technology transfer, and product launch. By offering these services, Solmedix facilitates the smooth commercialization of startups and innovators with promising medical device ideas, helping to bring new solutions to the healthcare market.
InCerebro
Seed Round in 2021
InCerebro is a pharmaceutical research and development company that offers drug development.
Pharos iBio
Series C in 2021
Pharos iBio Co. is a company focused on the development of innovative treatments for rare and intractable diseases. Utilizing a cutting-edge drug development platform that incorporates big data and artificial intelligence, Pharos iBio aims to address significant unmet medical needs. The company’s product pipeline includes several candidate drugs, such as PHI-101-AML for refractory or relapsed acute myeloid leukemia, PHI-101-OC for platinum-resistant or refractory ovarian cancer, and PHI-101-TNBC for metastatic triple-negative breast cancer. Additionally, Pharos iBio is advancing other candidates, including PHI-201, PHI-301, and PHI-501, as part of its commitment to improving patient outcomes in challenging therapeutic areas.
Nemesis
Seed Round in 2021
Nemesis provides bio and medical device vendors and service providers with Intelligent biosignal processing solutions. Nemesis has technologies like biosensors, bio-signal processing, and wireless communication, which provide compact, low-power, and accurate semiconductor solutions that anyone can use. Nemesis semiconductor-based intelligent bio signal processing solution can be expanded to diagnose biomarkers in areas such as heart rate, electrocardiogram, blood pressure, and virus detection. Nemesis will do everything possible to improve the quality of our partners' products and services as a result of this.
Panolos Bioscience
Series A in 2021
Panolos Bioscience is a biotechnology company focused on developing innovative biological drugs for cancer therapy. The company utilizes a multi-specific drug creation platform, which features anti-angiogenesis-based artifact re-targeting tri-specifics, known as ART. This technology aims to minimize the side effects commonly associated with single-target protein therapeutics and supports the expansion of diverse drug pipelines through its multi-targeting approach. By offering novel drugs and treatment options, Panolos Bioscience strives to improve patient outcomes in cancer care.
Washswat Inc. is a South Korean company established in 2015 that specializes in on-demand mobile laundry services. Based in Seoul, it operates through a network of specialized facilities and personnel that handle washing and drying. Initially launched in the Gangnam area, known for its concentration of high-end cleaners, Washswat has strategically expanded its services to various regions, including Seongnam, Hanam, Goyang, Gwangmyeong, Yongin, Suwon, Anyang, and Gwacheon, becoming a leader in mobile laundry services in Korea. The company utilizes IT technology to enhance its offerings, providing customers with a mobile application that allows them to track their laundry process and schedule pickups and deliveries from their doorstep. Washswat's meticulous approach ensures that every item is carefully recorded to prevent loss, thereby delivering a reliable service tailored to meet customer needs.
Wefun is a company focused on managing office snacks, offering a diverse selection to meet the tastes of employees. They employ a dedicated snack curator who conducts personalized consultations to understand client preferences and recommend new products. This tailored approach allows businesses to order weekly snacks that align with the specific tastes of their workforce, enhancing the overall workplace experience.
Nexel is a biotechnology research firm focused on advancing drug discovery and biotherapeutics. The company specializes in developing high-quality induced pluripotent stem cell (iPSC) products using embryonic stem cell technology. By providing innovative solutions and drug discovery pipelines, Nexel aims to address unmet medical needs and enhance therapeutic options for various diseases.
Localstitch
Series A in 2021
Localstitch, founded in 2013 and based in South Korea, operates as a provider of shared office and residential spaces. The company aims to create environments where individuals can live, work, and launch businesses. By designing and managing flexible spaces, Localstitch facilitates collaboration among professionals while offering affordable rates that alleviate the financial burdens often associated with urban living. This approach allows clients to concentrate on their creative endeavors in a supportive community setting.
Rounded is an art creator platform that sells living, furniture, and kitchen products.
Onegene Biotechnology
Series A in 2021
Onegene Biotechnology is a biotechnology company focused on developing innovative protein-based drugs to treat cancer, metabolic, and inflammatory diseases. The company specializes in creating highly potent tri- or multispecific protein drugs by combining various molecular types, including Fab fragments, scFv, sdAb, peptides, cytokines, agonists/antagonists, and enzymes. This approach allows for an unprecedented level of design flexibility with optimized physical properties, opening new avenues for developing complex protein drugs that are feasible to manufacture. Onegene's technology involves protein conjugation, which connects two separate proteins to produce therapeutic recombinant proteins through post-translational fusion. This method enables the production of multi-target proteins with large molecular weights, providing prolonged holistic benefits for treating complex and multifactorial diseases.
APITBIO is a biotechnology company focused on the research and development of antibody therapeutics, particularly in the field of anti-cancer drugs. The company utilizes a comprehensive platform that encompasses various stages of drug development, including screening, discovery, optimization, and production of monoclonal and double antibodies. By advancing its research in antibody therapeutics, APITBIO aims to address significant unmet medical needs within the oncology sector, providing hospitals with innovative treatment options for cancer patients.
Influential
Series C in 2021
Influential Inc. is a South Korean company founded in 2008 that specializes in publishing books and audiobooks. It operates a subscription service for its online audiobooks, catering to a wide audience. Additionally, Influential organizes lectures and seminars featuring industry experts, offering professional speaking services to companies and organizations around the globe. The company's focus on disseminating knowledge through various formats positions it as a key player in the educational and professional development sectors.
URBAN Digital Marketing
Seed Round in 2021
URBAN Digital Marketing is a full-service digital marketing firm.
Share It
Venture Round in 2021
Share It is an IT social network platform that offers space mediation services for idle schools.
DataCommand
Venture Round in 2021
DataCommand Inc. is a system software development company based in Seoul, South Korea, founded in 2017. The company specializes in developing and supplying data backup, data replication, and integrated data management systems. Its innovative technology addresses challenges associated with the growing volume of data by tracking the entire lifecycle of data, including generation, updates, and destruction. This capability ensures business continuity by enabling immediate access to data, allowing clients to implement flexible and efficient data protection solutions while reducing costs. DataCommand primarily serves companies within the IT infrastructure sector in South Korea.
H2K is an edutech company based in Daejeon, South Korea, that specializes in an artificial intelligence-driven application for teaching the Korean language to infants and toddlers. The application utilizes a sound-based approach and emphasizes the phonics method to deliver personalized educational experiences. It offers a variety of engaging programs filled with games and activities, along with real-time assessments of learning progress, facilitating quick comprehension and mastery of the language for young learners.
OGQ is a developer of a social creator platform that facilitates connections between creators and their fans, allowing creators to sell their works directly. The platform hosts a diverse array of content, including images, videos, music, stickers, illustrations, and graphics in various formats, such as PSD and AI. With over 14 million creators, including photographers, musicians, and illustrators, OGQ serves a global audience, with significant user bases in the United States, India, and Russia. The platform has achieved substantial popularity, boasting 240 million app downloads and 2.6 billion content downloads, while maintaining a high user rating of 4.6 on Google Play. OGQ supports content in 30 languages, providing users with high-definition materials for various applications, including messaging services and search platforms.
Machbase Inc specializes in providing a columnar database management system designed to process time series log data generated by various machines within IT infrastructures, particularly in the context of the Internet of Things (IoT). The company offers different editions of its software, including an embedded edition for applications such as unified threat management and factory automation, and a standard edition focused on real-time data analysis for security management and energy management systems. Machbase's solutions enable the collection, storage, indexing, retrieval, analysis, and visualization of big data in real-time, catering to industries such as steel, automotive, pharmaceuticals, and logistics. Founded in 2016 and based in San Jose, California, Machbase aims to enhance corporate productivity by delivering integrated information management solutions that support quick adaptation to process innovations and operational changes.
Autotelic Bio
Series A in 2020
Autotelic Bio is a biotechnology company specializing in the research and development of innovative anti-cancer drugs. The company aims to enhance the efficacy and reduce the side effects of existing oncology treatments through the precise targeting and optimization of therapies. In addition to its focus on oncology, Autotelic Bio is also involved in developing immuno-oncology drugs that address conditions such as diabetes, hypertension, and diseases affecting the central nervous system. By pursuing advanced therapeutic solutions, Autotelic Bio seeks to improve patient outcomes and contribute to the evolving field of cancer treatment.
BnH Research
Series A in 2020
BnH Research is a drug development and research firm focused on creating therapeutics for patients with chronic conditions. The company specializes in verifying the efficacy of new and existing drug candidates, providing essential contract-based research services to pharmaceutical companies. BnH Research aims to address unmet medical needs by developing drug candidates that particularly enhance cortical plasticity, which is crucial for treating central nervous system conditions such as Alzheimer's Disease, PTSD, addiction, amblyopia, and stroke. Through its innovative approaches, the firm seeks to improve patient outcomes and advance the field of drug development.
Super Kitchen
Series A in 2020
Super Kitchen is a food store chain that specializes in offering a variety of culinary products, including beef soups, tomato meatballs, and altari pickles. The company focuses on providing fresh and healthy ingredients along with refrigerated foods designed for side dishes, as well as curated recipes. By emphasizing quality and variety, Super Kitchen aims to enhance the dining experience for its customers, allowing them to enjoy new and diverse delicacies on a daily basis.
Ubix Therapeutics
Series B in 2020
Ubix Therapeutics, Inc. is a research and development company based in Seoul, South Korea, focused on the development of anti-cancer drugs utilizing a proprietary proteolysis targeting chimera platform. The company employs advanced inhibitor technology that degrades specific target proteins within cells, aiming to enhance therapeutic efficacy for various cancers. By binding to proteins associated with disease, Ubix Therapeutics seeks to provide life-saving medications for patients, thereby supporting both patients and medical professionals in the fight against cancer.
SecuLetter
Series B in 2020
SecuLetter Co Ltd is a company that specializes in cybersecurity solutions designed to combat a range of cyber threats, including malware and phishing attacks. Utilizing hybrid approaches that combine both static and dynamic analysis, SecuLetter effectively detects unknown attacks, even when cybercriminals attempt to conceal malicious links and attachments. The company focuses on diagnosing and analyzing security vulnerabilities at the assembly level of non-executable files, enabling it to achieve a high detection rate for security threats and exploits. SecuLetter's primary business areas encompass email security, secure data transmission between networks, web service file security, document centralization, cloud support security, and security threat intelligence, ensuring comprehensive protection against emerging cyber threats.
PDC*line Pharma
Series B in 2020
PDC*line Pharma is a clinical-stage biotech company based in France and Belgium, specializing in the development of innovative active immunotherapies for cancer. The company utilizes a proprietary allogeneic cell line of Plasmacytoid Dendritic Cells (PDC*line) that are loaded with cancer antigens to enhance the immune response against tumors. Founded in April 2014 in Grenoble by Laurent Levy and Joel Plumas, PDC*line Pharma evolved from a research program at the French Blood Bank that developed the PDC line from a patient with PDC leukemia. The company aims to provide more effective cancer treatments by leveraging these potent and scalable dendritic cell lines to boost antitumor responses, including those targeting neoantigens, and to stimulate specific cytotoxic T-cell activity beyond what conventional vaccines can achieve. Eric Halioua joined the company in 2016 and has since served as President and CEO, guiding its progression into clinical development.
Funda is a P2P finance service that connects multiple investors to sound stores that need funds and creates a financial service.
Curacle
Venture Round in 2020
Curacle Co Ltd is a biopharmaceutical company focused on developing innovative drugs aimed at treating incurable diseases linked to the aging process and damage to blood vessels. Utilizing advanced technology, Curacle seeks to address significant medical challenges posed by conditions that result from the deterioration of vascular health. The company's commitment to research and development positions it at the forefront of the biopharmaceutical industry, as it strives to create effective therapeutic solutions for patients suffering from these critical health issues.
ASIC Land
Venture Round in 2020
ASIC Land develops technology that transcends the barriers and produces chips in the SoC, front-end, DFT, and back-end sectors.
Three Friends
Venture Round in 2020
Three Friends is a company that provides online and mobile accounting and tax processing automation services, specifically designed to assist small business owners. By leveraging artificial intelligence and big data, Three Friends offers a platform that enables businesses to track performance, analyze sales and purchase data, and manage cash flow effectively. The platform employs various analysis, prediction, and recommendation techniques to deliver insightful accounting information, allowing businesses to gain a clear understanding of their financial position within the market. As the company expands its services, it continues to focus on meeting the needs of small business owners.
Clecell
Venture Round in 2020
Clecell is a biotechnology company that specializes in bioprinting and tissue engineering technology. The company focuses on the research and development of artificial tissues, including advanced models of human skin and respiratory epithelium. Utilizing its proprietary 3D bioprinter and innovative bioprinting techniques, Clecell aims to create solutions that help prevent infections and mitigate tissue injuries by leveraging the functionality of the mucociliary elevator. Through its work, Clecell seeks to advance the field of regenerative medicine and improve healthcare outcomes.
VR ZONE
Venture Round in 2020
VR ZONE is a company that operates a virtual reality theme park designed to create a futuristic atmosphere featuring spaceship capsules and unique structures. It specializes in content creation, simulator development, and sales services, allowing multiple users to engage in immersive experiences simultaneously. By enabling participants to watch and interact with early stories, VR ZONE enhances the overall engagement and immersion for its users, making it a distinctive player in the entertainment and simulation industry.
Hey Joyce
Seed Round in 2019
Hey Joyce is a women's career growth and problem-solving management consulting platform that connects women online.
Gluup is a branding agency that specializes in research and development as well as brand marketing. It operates a brand commerce platform that aims to build and promote various food and beverage franchises. The company focuses on home meal replacement products and functions as a distributor and seller of business-to-business-to-consumer products. By utilizing multiple on-and-off channels, Gluup offers customers a diverse range of products under a unified platform, enhancing brand visibility and accessibility.
Localstitch
Seed Round in 2019
Localstitch, founded in 2013 and based in South Korea, operates as a provider of shared office and residential spaces. The company aims to create environments where individuals can live, work, and launch businesses. By designing and managing flexible spaces, Localstitch facilitates collaboration among professionals while offering affordable rates that alleviate the financial burdens often associated with urban living. This approach allows clients to concentrate on their creative endeavors in a supportive community setting.
Logispot is a South Korean company founded in 2016 that specializes in digital logistics and freight transport services. It operates a platform designed to streamline the fragmented cargo transportation market by offering integrated transport management and efficient handling of incoming and outgoing shipments. The platform also facilitates seamless integration with customers' internal systems, ensuring a hassle-free experience in the movement of goods and services. By providing systematic functions, Logispot aims to enhance the efficiency and convenience of logistics operations for its clients.
TWC provides IT solutions, HR, consulting and optimized business operation services by incorporating artificial intelligence.
Oncorus, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, dedicated to developing innovative viral immunotherapies for cancer treatment. The company's lead product candidate, ONCR-177, utilizes an oncolytic herpes simplex virus type 1 platform and is currently undergoing Phase I clinical trials to assess its efficacy against various cancers. In addition to ONCR-177, Oncorus is advancing its ONCR-GBM program aimed at treating brain cancer, along with synthetic viral immunotherapies derived from Coxsackievirus A21 and Seneca Valley Virus. The company has established a clinical trial collaboration with MSD International GmbH to evaluate the safety and tolerability of ONCR-177 in combination with Merck’s KEYTRUDA immunotherapy. Founded in 2015, Oncorus is committed to improving patient outcomes and has pledged to contribute a portion of its product sales to support cancer research and care in developing regions.
I-ON Digital
Venture Round in 2019
I-ON Digital Corp. is a software development company headquartered in Seoul, South Korea, specializing in unstructured data management and digital marketing solutions. The company provides a range of enterprise content management systems, including I-ON Content Server and I-ON Digital Asset Management System, alongside digital experience solutions such as web analytics and mobile contract platforms. I-ON Digital also offers smart mobility and analytics tools, catering to clients in various regions including South Korea, Japan, and Southeast Asia. Its energy management solutions aim to optimize electricity consumption through customizable demand response systems and a proprietary predictive analytics engine. Founded in 1999, I-ON Digital has evolved to address diverse market needs, including sports and IT convergence services that enhance the management of professional sports events.
Wing Eat
Venture Round in 2019
Wing Eat is an online food market specializing in high-quality food products through its retail platform. The company provides a diverse range of offerings, including ready-to-eat meals, pet foods, and various household items. By focusing on fresh and quality products, Wing Eat enables customers to conveniently access and have their purchases delivered directly to their doorstep.
Immunomax
Venture Round in 2019
Immunomax is a biotechnology company focused on developing immunology-based biopharmaceuticals, particularly in the field of cancer treatment. The company specializes in allogeneic gamma delta CAR-T cell therapies, which aim to enhance patients' immune responses against cancer. Additionally, Immunomax produces animal cell lines designed for high-efficiency biopharmaceutical manufacturing. By leveraging these advanced technologies, Immunomax seeks to provide healthcare professionals with innovative solutions to improve patient outcomes and strengthen immunity in the fight against various diseases.
GenoBio
Venture Round in 2018
GenoBio is a medical technology company specializing in non-invasive liquid biopsy research. It develops ultra-sensitive genomic tools that facilitate the accurate and cost-effective detection of genetic variations associated with cancer, inherited diseases, and infectious diseases. By providing these advanced tools, GenoBio enables research institutions and laboratories to perform precise biopsies, enhancing the capabilities of genetic analysis in various medical fields.
Mr. Milk
Venture Round in 2018
Mr. Milk is a manufacturer of dairy products, specializing in the production of yogurt, cheese, and ice cream. The company is committed to providing reliable and fresh products, utilizing raw milk to ensure the quality and healthiness of its offerings. By focusing on freshness and a diverse range of dairy options, Mr. Milk caters to consumers seeking nutritious and tasty dairy alternatives.
JI Tech
Venture Round in 2018
JI Tech is a domestic manufacturer specializing in ultra-precision semiconductor compounds, established in 2014. The company focuses on producing ultra-fine precursors for semiconductors and operates in the plasticized material manufacturing sector. Its product range includes precursors, mask cases, and various other related items. JI Tech has demonstrated consistent sales and profitability, attributed to ongoing technological development and effective customer engagement. In recognition of its achievements, the company was named a global small giant in Jeollabuk-do in 2021.
Stat
Venture Round in 2018
Stat & Co develops a gaming information platform that provides its users with the stats about baseball and other sports. The company's platform specializes in managing bowling game records, baseball clubs, a platform for badminton players, and a sports e-commerce website.
H9Pitch
Venture Round in 2018
H9Pitch Studio is a design studio that focuses on serving the sports industry and related cultural sectors. It provides a range of multimedia design services tailored to both amateur and professional sports clients. H9Pitch specializes in concept origination and creative direction, offering expertise in videography and photography. Additionally, the studio engages in event planning and exhibition services, ensuring comprehensive support for its clients' needs. Through its diverse offerings, H9Pitch aims to enhance the visual and experiential aspects of sports and cultural events.
Monolith
Seed Round in 2017
Monolith Inc., founded in 2014 and headquartered in Jeju, South Korea, specializes in developing mobile games. In addition to its gaming ventures, the company is also focused on creating innovative smart parks that integrate technology with play spaces for children. By combining entertainment and recreational infrastructure, Monolith aims to enhance the play experience and foster creative environments for younger audiences.
OTD is an operator of multi-brand gourmet restaurants located in office buildings and shopping malls throughout South Korea. The company specializes in creating food courts that offer a diverse selection of dining options, catering to a wide range of tastes. By providing quality food at affordable prices, OTD aims to serve the general public, making dining accessible and enjoyable in various urban settings.
Woman’s Talk
Venture Round in 2017
Woman’s Talk is viewed by its users as a ‘friendly’ platform for the way in which it provides users with pricing and product related information. A key factor in the success of the business is the requirement for product brands to provide their most competitive price and product guarantee. Woman’s Talk in return provides a lower service fee compared to traditional distribution services whilst also providing the full marketing support required to promote the product.
Boud
Venture Round in 2017
Boud is a design company that merges design and technology to enhance user experiences globally. Originally established as a design studio, Boud specializes in brand consulting, product design, and place design. The company focuses on brand strategy and visualization, product design strategy, and color, material, and finish (CMF) coordination, ensuring a comprehensive approach to brand experience. By guiding businesses from initial concepts to finalized visual identities and products or spaces, Boud aims to create meaningful value through innovative design solutions.
Suji's Korean Cuisine
Venture Round in 2017
Suji's Korean Cuisine offers change of ready for retail, ready to eat food and services.
Jeju Beer
Series A in 2016
Jeju Beer Company, Limited is a brewery based in Jeju, South Korea, founded in 2015. The company specializes in the production of beer and is actively involved in the alcoholic beverage manufacturing industry. Jeju Beer aims to capture the unique essence of its island origin in its products, contributing to the local brewing scene and promoting the region's distinct flavors.
VNPT EPAY
Acquisition in 2016
VNPT EPay is a provider of electronic payment services, specializing in advanced technology solutions for Internet and mobile users as well as banking institutions. The company develops an online payment portal that facilitates a range of financial transactions, including online payment gateways, interbank money transfers, deposit codes, and electronic wallets. By offering these services, VNPT EPay enables customers to effectively manage their daily financial activities, enhancing convenience and efficiency in electronic transactions.
VRotein
Venture Round in 2016
VRotein Inc. is a company that specializes in designing and developing Virtual Reality games. Founded in 2012 and headquartered in Gyeonggi-do, South Korea, VRotein offers a comprehensive solution tailored for the VR arcade business. The company focuses on creating immersive gaming experiences that cater to the growing demand for virtual entertainment. Through its innovative approach and dedication to quality, VRotein aims to enhance the user experience in the VR gaming industry.
CEFO
Venture Round in 2015
CEFO is a company focused on the research, development, and commercialization of stem cell therapy products. It develops a range of biomedical products that support researchers in the field of regenerative medicine. These products include solutions for primary cultured cells, cell culture fluids, collagenase, and specialized storage boxes for cell freezing. By providing these essential tools, CEFO enables scientists and researchers to advance their work in stem cell therapies and regenerative medicine applications.
NovMetapharma Company
Venture Round in 2014
NovMetapharma Company, established in 2010 and headquartered in Seoul, South Korea, specializes in designing and developing therapeutic agents for metabolic diseases. Its primary focus is a Phase IIa clinical trial drug for Type 2 diabetes and obesity, with additional pipelines for Alzheimer's disease, immune system disorders, osteoporosis, and non-alcoholic fatty liver diseases. The company aims to grow and achieve profitability in the metabolic disease treatment market, addressing the global health threat posed by aging populations and changing dietary habits. NovMetapharma seeks to develop alternative antidiabetic agents with improved insulin resistance efficacy, in response to the limitations of existing drugs. It has collaborated with the VA Institute to commercialize research results and original technologies, positioning itself as a global pharmaceutical company.
ArenaCast
Venture Round in 2014
ArenaCast is a rapidly growing global provider of an interactive platform focused on esports, gaming, and over-the-top (OTT) digital content. The company has developed a gaming platform that integrates streaming services with gaming experiences, positioning itself within the evolving landscape of Web 3.0 and the metaverse. By offering a unique combination of features, ArenaCast enables users to engage with a variety of digital content, enhancing the interactive experience for both gamers and esports enthusiasts.
Intin
Venture Round in 2013
Intin is a company focused on researching, manufacturing, and selling digital healthcare products. It develops self-diagnostic medical devices that enhance health management through technology. Notably, its offerings include a smartphone application that monitors sperm count and activity, as well as tools for tracking ovulation dates. Additionally, Intin provides other medical devices, such as non-contact thermometers and ovulation analyzers. By leveraging digital technology, the company aims to streamline healthcare processes and reduce the need for hospital visits for related checkups, ultimately saving users time and money.
BNH Cosmetics
Venture Round in 2013
BNH Cosmetics is a Seoul-based producer of perfumes and cosmetics, specializing in a diverse range of products including skincare, suncare, mask packs, base makeup, makeup tools, and eye makeup. The company has established itself as a prominent competitor in the K-beauty industry, focusing on innovation to enhance the consumer experience. By continuously striving for advancements and improvements, BNH Cosmetics aims to drive progress within the beauty sector while showcasing its exceptional products on a global scale.